MDR Pricing: Comparing Asset-Based and Ingestion-Based Costs
At a glance
Low rather than Medium: UK relevance is 40 of 100, little UK-specific signal so far.
Briefing
There is no written leader briefing for this story yet. The summary below says what is known so far.
Next steps
Monitor- For awareness — no fixed action deadline for this reporting
No technical write-up beyond the summary below yet.
Next steps
Monitor- No immediate technical action — track if your estate depends on the products or vendors discussed
Summary
- When comparing MDR pricing, it helps to understand what the same annual budget would buy from each provider.
- Two proposals with similar prices may give analysts access to different evidence, retain it for different periods, or leave your team with different responsibilities.
- Those differences can affect what happens when you need to investigate a compromised account or trace an attacker’s low-and-slow activity across your environment.
Pulse
Last change 45m ago · Next recheck 14 Nov 2026, 17:19 UK time
- Story13 Nov 2026, 17:19 UK time · 45m ago
Linked reporting from Rapid7 Blog (research).
Read source (Rapid7 Blog)
1 entry so far. The timeline chart appears once this story has more history.
Sources
- Rapid7 BlogResearcher
MDR Pricing: Comparing Asset-Based and Ingestion-Based Costs
How we know
Statements extracted from sources. Higher confidence means stronger corroboration.
- ClaimedHeadline60% confidence
MDR Pricing: Comparing Asset-Based and Ingestion-Based Costs
- ProbableSummary fact75% confidence
When comparing MDR pricing, it helps to understand what the same annual budget would buy from each provider. Two proposals with similar prices may give analysts access to different evidence, retain it for different periods, or leave your team with different responsibilities. Those differences can affect what happens when you need to investigate a compromised account or trace an attacker’s low-and-slow activity across your environment.